Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

Germaine Hanquet; Pierre Van Damme; Daniel Brasseur; Xavier De Cuyper; Simon Gregor; Martin Holmberg; Rebecca Martin; Zsuzsanna Molnár; Maria Grazia Pompa; René Snacken; Marianne van der Sande; Marc Van Ranst; Angela Wirtz; Pieter Neels

doi:10.1016/j.vaccine.2010.10.079

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

Germaine Hanquet, Pierre Van Damme, Daniel Brasseur, Xavier De Cuyper, Simon Gregor, Martin Holmberg, Rebecca Martin, Zsuzsanna Molnár, Maria Grazia Pompa, René Snacken, Marianne van der Sande, Marc Van Ranst, Angela Wirtz, Pieter Neels

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.

Original language	English
Pages (from-to)	370-7
Number of pages	8
Journal	Vaccine
Volume	29
Issue number	3
DOIs	https://doi.org/10.1016/j.vaccine.2010.10.079
Publication status	Published - 10 Jan 2011

Keywords

Adjuvants, Immunologic
Adolescent
Child
Child, Preschool
Female
Humans
Influenza A Virus, H1N1 Subtype
Influenza Vaccines
Influenza, Human
Pandemics
Pregnancy
Pregnancy Complications, Infectious
Vaccination
Young Adult

Access to Document

10.1016/j.vaccine.2010.10.079

Cite this

Hanquet, G., Van Damme, P., Brasseur, D., De Cuyper, X., Gregor, S., Holmberg, M., Martin, R., Molnár, Z., Pompa, M. G., Snacken, R., van der Sande, M., Van Ranst, M., Wirtz, A., & Neels, P. (2011). Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine, 29(3), 370-7. https://doi.org/10.1016/j.vaccine.2010.10.079

@article{4db50c8e409a4edd954685eedc8378ad,

title = "Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)",

abstract = "This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.",

keywords = "Adjuvants, Immunologic, Adolescent, Child, Child, Preschool, Female, Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines, Influenza, Human, Pandemics, Pregnancy, Pregnancy Complications, Infectious, Vaccination, Young Adult",

author = "Germaine Hanquet and {Van Damme}, Pierre and Daniel Brasseur and {De Cuyper}, Xavier and Simon Gregor and Martin Holmberg and Rebecca Martin and Zsuzsanna Moln{\'a}r and Pompa, {Maria Grazia} and Ren{\'e} Snacken and {van der Sande}, Marianne and {Van Ranst}, Marc and Angela Wirtz and Pieter Neels",

year = "2011",

month = jan,

day = "10",

doi = "10.1016/j.vaccine.2010.10.079",

language = "English",

volume = "29",

pages = "370--7",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "3",

}

Hanquet, G, Van Damme, P, Brasseur, D, De Cuyper, X, Gregor, S, Holmberg, M, Martin, R, Molnár, Z, Pompa, MG, Snacken, R, van der Sande, M, Van Ranst, M, Wirtz, A & Neels, P 2011, 'Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)', Vaccine, vol. 29, no. 3, pp. 370-7. https://doi.org/10.1016/j.vaccine.2010.10.079

TY - JOUR

T1 - Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

AU - Hanquet, Germaine

AU - Van Damme, Pierre

AU - Brasseur, Daniel

AU - De Cuyper, Xavier

AU - Gregor, Simon

AU - Holmberg, Martin

AU - Martin, Rebecca

AU - Molnár, Zsuzsanna

AU - Pompa, Maria Grazia

AU - Snacken, René

AU - van der Sande, Marianne

AU - Van Ranst, Marc

AU - Wirtz, Angela

AU - Neels, Pieter

PY - 2011/1/10

Y1 - 2011/1/10

N2 - This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.

AB - This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.

KW - Adjuvants, Immunologic

KW - Adolescent

KW - Child

KW - Child, Preschool

KW - Female

KW - Humans

KW - Influenza A Virus, H1N1 Subtype

KW - Influenza Vaccines

KW - Influenza, Human

KW - Pandemics

KW - Pregnancy

KW - Pregnancy Complications, Infectious

KW - Vaccination

KW - Young Adult

U2 - 10.1016/j.vaccine.2010.10.079

DO - 10.1016/j.vaccine.2010.10.079

M3 - Article

C2 - 21075164

SN - 0264-410X

VL - 29

SP - 370

EP - 377

JO - Vaccine

JF - Vaccine

IS - 3

ER -

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

Abstract

Keywords

Access to Document

Fingerprint

Cite this